Schlieren, Switzerland

Marcel Emmerling

USPTO Granted Patents = 1 



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marcel Emmerling: Innovator in Scalable Fermentation Processes

Introduction

Marcel Emmerling is a notable inventor based in Schlieren, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of fermentation processes. His innovative work has led to the creation of a patented technology that enhances the production of essential proteins.

Latest Patents

Marcel Emmerling holds a patent for a scalable fermentation process. This invention provides a robust method for expressing a capsid protein of a bacteriophage, which forms a virus-like particle (VLP) through self-assembly. The process is designed to be scalable to commercial production levels, with a controlled expression rate of the capsid protein to improve the yield of soluble capsid protein. The innovation combines the benefits of fed-batch culture and lactose-induced expression systems, utilizing specific process parameters to enhance promoter repression during the growth phase and ensure high plasmid retention throughout the process.

Career Highlights

Throughout his career, Marcel has worked with prominent companies in the biotechnology sector. Notable among these are Kuros Biosciences AG and Cytos Biotechnology AG. His experience in these organizations has contributed to his expertise in fermentation technologies and protein expression.

Collaborations

Marcel has collaborated with several professionals in his field, including Frank Hennecke and Holger Pfründer. These partnerships have furthered his research and development efforts, leading to advancements in biotechnological applications.

Conclusion

Marcel Emmerling is a distinguished inventor whose work in scalable fermentation processes has the potential to impact the biotechnology industry significantly. His innovative approach to protein expression continues to pave the way for advancements in commercial production methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…